Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MHLW Research Team Develops Universal Flu Vaccine

This article was originally published in PharmAsia News

Executive Summary

A research team at the Ministry of Health, Labor and Welfare announced Jan. 29 that it has developed a universal flu vaccine. Led by National Institute of Infectious Disease Chief Researcher Tetsuya Uchida, the team made the vaccine based on common protein found in three highly mutated flu virus types, H5N1, H1N1 and a Hong Kong type. The team confirmed efficacy of the vaccine through preclinical trials. The vaccine is estimated to take several years before it will be available to the public. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts